Fuminori Yoshida
Gründer bei SYMBIO PHARMACEUTICALS LIMITED
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Fuminori Yoshida
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYMBIO PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 25.03.2005 | - |
Vorstandsvorsitzender | 25.03.2005 | - | |
Gründer | 25.03.2005 | - | |
Präsident | 25.03.2005 | - |
Karriereverlauf von Fuminori Yoshida
Ehemalige bekannte Positionen von Fuminori Yoshida
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Syntex Japan Co., Ltd. | Corporate Officer/Principal | 01.01.1993 | 15.09.2009 |
Präsident | 15.09.2009 | - | |
AHS Japan, Inc. | Corporate Officer/Principal | - | - |
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Gründer | 01.01.1993 | - |
Präsident | 01.01.1993 | - | |
MITSUBISHI CORPORATION | Corporate Officer/Principal | - | - |
Nippon Bio-Rad Laboratories | Gründer | 03.08.2009 | - |
Präsident | 03.08.2009 | - |
Ausbildung von Fuminori Yoshida
Harvard University | Graduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Gakushuin University | Undergraduate Degree |
Statistik
International
Japan | 8 |
Vereinigte Staaten | 3 |
Operativ
President | 4 |
Founder | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MITSUBISHI CORPORATION | Distribution Services |
SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 4 |
---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
Nippon Bio-Rad Laboratories | |
AHS Japan, Inc. | |
Syntex Japan Co., Ltd. |
- Börse
- Insiders
- Fuminori Yoshida
- Erfahrung